<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04897256</url>
  </required_header>
  <id_info>
    <org_study_id>R01HD100383</org_study_id>
    <secondary_id>R01HD100383</secondary_id>
    <nct_id>NCT04897256</nct_id>
  </id_info>
  <brief_title>Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation</brief_title>
  <official_title>Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this intervention is to explore the effectiveness of a Turning Boot Camp&#xD;
      rehabilitation intervention to improve quality of turning in participants with Parkinson's&#xD;
      Disease (PD). A unique exercise program has been developed - Turning Boot Camp - that&#xD;
      involves practicing turning while dual-tasking with a body-support harness with 5 stations;&#xD;
      Flexibility, Anticipatory Weight Shifting, Tai Chi, Boxing, and Agility. The 60 participants&#xD;
      with PD, and a history of falls in the previous 12 months, will be randomized into a 6-week,&#xD;
      3x/week, one-on-one Turning Boot Camp group or No-Intervention Control group. This pilot&#xD;
      intervention study will determine the number of subjects needed for a future clinical trial&#xD;
      and will determine the sensitivity to change with rehabilitation our daily life turning&#xD;
      quality measures (mean and variability of number of steps to turn, turn amplitude, turn&#xD;
      velocity). Investigators predict that the Turning Boot Camp rehabilitation intervention will&#xD;
      improve turning in daily life enough to justify a larger clinical trial.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 15, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Investigators involved in measuring outcomes, will remain blinded to the group that participants are assigned to.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Turn Angle</measure>
    <time_frame>6 weeks</time_frame>
    <description>Change in angle amplitude averaged from daily living monitoring</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Falls Efficacy Scale International</measure>
    <time_frame>6 weeks</time_frame>
    <description>A 16 item self-administered questionnaire to assess fear of falling. Score range 16-64 with higher score indicating more fear of falling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in prospective fall rate</measure>
    <time_frame>52 weeks</time_frame>
    <description>Number of prospective falls recorded for 12 months starting from the end of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Global Impression of Change</measure>
    <time_frame>6 weeks</time_frame>
    <description>Question of participant's rating of mobility. Score range from 1-7 with 1-3 indicating improvement, 4 no change, and 5-7 worsening of mobility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in variability in number of steps to complete a turn</measure>
    <time_frame>6 weeks</time_frame>
    <description>Coefficient of variation in the number of steps in a turn, averaged from daily monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in number of steps to complete a turn</measure>
    <time_frame>6 weeks</time_frame>
    <description>Number of steps in a turning averaged from daily monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in turn peak velocity</measure>
    <time_frame>6 weeks</time_frame>
    <description>Peak velocity of turns averaged from daily monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in turn angle amplitude</measure>
    <time_frame>6 weeks</time_frame>
    <description>Peak size of turn angles averaged from daily monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in turn duration</measure>
    <time_frame>6 weeks</time_frame>
    <description>Time to complete turns averaged from daily monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in turn trunk jerk</measure>
    <time_frame>6 weeks</time_frame>
    <description>A measure of smoothness of turning; the rate of change of acceleration during a turn averaged from daily monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variability of double-support time</measure>
    <time_frame>6 weeks</time_frame>
    <description>Coefficient of variation in time of double-support phase</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in mini-Balance Evaluation Systems Test</measure>
    <time_frame>6 weeks</time_frame>
    <description>Clinical measure of four balance domains-anticipatory, reactive, sensory, and dynamic gait. Scores range from 0-28 with higher scores indicating worse balance</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Clinical Global Impression of Change</measure>
    <time_frame>6 weeks</time_frame>
    <description>Question of clinician's rating of participant mobility. Score range from 1-7 with 1-3 indicating improvement, 4 no change, and 5-7 worsening of mobility.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Parkinson's Disease Questionnaire-39</measure>
    <time_frame>6 weeks</time_frame>
    <description>A 39 item self-report questionnaire to assess Parkinson's disease specific health related quality in eight domains of quality of life. Each item scores from 0 (never) to 4 (always). Sub-scale scores and a Parkinson's Disease summary index (PDSI; sum of eight subsections/8) representing the global health-related quality of life will be calculated, with higher scores representing worse quality of life</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Unified Parkinson's Disease Rating Scale, Part III</measure>
    <time_frame>6 weeks</time_frame>
    <description>A clinical scale to assess severity of motor symptoms in Parkinson's disease. Each item is scored 0 (normal) to 4 (severe) with a score range from 0-132</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Activities-Specific Balance Confidence Scale</measure>
    <time_frame>6 weeks</time_frame>
    <description>A 16-item self-report scale that participants rate their confidence in performing daily activities. Score range from 0-100% with 0% meaning no confidence and 100% completely confident</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Stride velocity</measure>
    <time_frame>6 weeks</time_frame>
    <description>Stride velocity during straight walking averaged from daily monitoring</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Stride length</measure>
    <time_frame>6 weeks</time_frame>
    <description>Stride length during straight walking averaged from daily monitoring</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Cadence</measure>
    <time_frame>6 weeks</time_frame>
    <description>The number of straight walking steps taken per minute averaged from daily monitoring</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in double support time</measure>
    <time_frame>6 weeks</time_frame>
    <description>The amount of time both feet were on the ground together during straight walking averaged from daily monitoring</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in angle of foot at heel strike</measure>
    <time_frame>6 weeks</time_frame>
    <description>The angle between the foot and the ground at heel strike during straight walking averaged from daily monitoring</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in variability of angle of foot at heel strike</measure>
    <time_frame>6 weeks</time_frame>
    <description>Coefficient of variation of the angle between the foot and the ground at heel strike during straight walking averaged from daily monitoring</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in number of turns per hour</measure>
    <time_frame>6 weeks</time_frame>
    <description>The average number of turns per hour measured during daily monitoring</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in number of bouts of walking and steps per day</measure>
    <time_frame>6 weeks</time_frame>
    <description>The average number of walking bouts and number of steps per day, measured during daily monitoring</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in duration of longest walking bout per day</measure>
    <time_frame>6 weeks</time_frame>
    <description>The longest bout of straight walking per day averaged from daily monitoring</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Turning Boot Camp Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the treatment group will attend supervised, 1-hour classes, 3 times per week for 6 weeks, one-on-one with the same exercise trainer, overseen by a physical therapist investigator.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Intervention Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in this group will be tested at baseline and 6 weeks later. They will go about their normal daily life during the 6 week period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Turning Boot Camp exercise program</intervention_name>
    <description>Based on the exercise motor learning principles, participants spend 10-15 minutes at each Exercise Station that focus on particular constraints of turning ability. The stations will focus on important underlying aspects of turning, such as weight-shifting, increasing axial rotation during functional turning tasks. Each station will be progressed across levels to make more challenging.</description>
    <arm_group_label>Turning Boot Camp Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of idiopathic PD from movement disorders neurologist with the United Kingdom&#xD;
             Brain Bank criteria of bradykinesia with 3 or more of the following - rest tremor,&#xD;
             rigidity, bradykinesia and balance problems not from visual, vestibular, cerebellar or&#xD;
             proprioceptive conditions&#xD;
&#xD;
          -  excellent response to levodopa&#xD;
&#xD;
          -  Hoehn &amp; Yahr 24 stages II-IV&#xD;
&#xD;
          -  ages 55-85 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Major musculoskeletal or neurological disorders, structural brain disease, epilepsy,&#xD;
             acute illness or health history, other than PD&#xD;
&#xD;
          -  no medical condition that precludes exercise&#xD;
&#xD;
          -  MoCA â‰¤ 21 or inability to follow directions&#xD;
&#xD;
          -  excessive use of alcohol or recreational drugs&#xD;
&#xD;
          -  recent change in medication&#xD;
&#xD;
          -  inability to stand and walk for 2 minutes without an assistive device&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fay Horak, PhD, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Austin Prewitt</last_name>
    <phone>503-418-2600</phone>
    <email>balance@ohsu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shelby Martin, MA</last_name>
    <phone>503-418-2602</phone>
    <email>martish@ohsu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Austin Prewitt</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 18, 2021</study_first_submitted>
  <study_first_submitted_qc>May 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Martina Mancini</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Upon reasonable request, we can share de-identified data related to study outcomes measures.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Data would be available 6 months after the end of data collection. Data will be stored in our laboratory data repository and so will be available indefinitely.</ipd_time_frame>
    <ipd_access_criteria>Data will not be stored on a public website, however researchers may contact us for access to the data. We will send data electronically via a secure server.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

